Search research articles
Contact Us
Filters
Showing results (61-70 of 184) with videos related to
Page
of 19
Sort By:
Anti-Cancer Drugs
|
March 1, 1997
In vitro cytotoxicity and DNA damage production in Chinese hamster ovary cells and topoisomerase II inhibition by 2-[2'-(dimethylamino)ethyl]-1, 2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones with substitutions at the 6 and 7 positions (azonafides)
C A Mayr, S M Sami, R T Dorr
Leukemia & Lymphoma
|
December 3, 2005
Correlates of imexon sensitivity in human multiple myeloma cell lines
Betty K Samulitis, Terry H Landowski, Robert T Dorr
Cancer Chemotherapy and Pharmacology
|
January 1, 1980
The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse
R T Dorr, D S Alberts, H S Chen
Anti-Cancer Drugs
|
February 1, 1991
Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA intercalating agents in vitro
R T Dorr, N G Shipp, K M Lee
Journal of Medicinal Chemistry
|
December 30, 2003
Chemical basis for the biological activity of imexon and related cyanoaziridines
Bhashyam S Iyengar, Robert T Dorr, William A Remers
Journal of Pharmacological Methods
|
November 1, 1980
Experimental model of doxorubicin extravasation in the mouse
R T Dorr, D S Alberts, H S Chen
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2000
The state-of-the-art in chemoprevention of skin cancer
S P Stratton, R T Dorr, D S Alberts
Investigational New Drugs
|
January 1, 1984
Bisantrene solubility and skin toxicity studies: efficacy of sodium bicarbonate as a local ulceration antidote
R T Dorr, Y M Peng, D S Alberts
Investigational New Drugs
|
September 17, 2013
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers
Terry H Landowski, Betty K Samulitis, Robert T Dorr
Anticancer Research
|
August 27, 2011
Interaction of dacarbazine and imexon, in vitro and in vivo, in human A375 melanoma cells
Betty K Samulitis, Robert T Dorr, H-H Sherry Chow
Page
of 19
Search research articles
Search
Showing results (61-70 of 184) with videos related to
Sort By:
Page
of 19
Anti-Cancer Drugs
|
March 1, 1997
In vitro cytotoxicity and DNA damage production in Chinese hamster ovary cells and topoisomerase II inhibition by 2-[2'-(dimethylamino)ethyl]-1, 2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones with substitutions at the 6 and 7 positions (azonafides)
C A Mayr, S M Sami, R T Dorr
Leukemia & Lymphoma
|
December 3, 2005
Correlates of imexon sensitivity in human multiple myeloma cell lines
Betty K Samulitis, Terry H Landowski, Robert T Dorr
Cancer Chemotherapy and Pharmacology
|
January 1, 1980
The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse
R T Dorr, D S Alberts, H S Chen
Anti-Cancer Drugs
|
February 1, 1991
Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA intercalating agents in vitro
R T Dorr, N G Shipp, K M Lee
Journal of Medicinal Chemistry
|
December 30, 2003
Chemical basis for the biological activity of imexon and related cyanoaziridines
Bhashyam S Iyengar, Robert T Dorr, William A Remers
Journal of Pharmacological Methods
|
November 1, 1980
Experimental model of doxorubicin extravasation in the mouse
R T Dorr, D S Alberts, H S Chen
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2000
The state-of-the-art in chemoprevention of skin cancer
S P Stratton, R T Dorr, D S Alberts
Investigational New Drugs
|
January 1, 1984
Bisantrene solubility and skin toxicity studies: efficacy of sodium bicarbonate as a local ulceration antidote
R T Dorr, Y M Peng, D S Alberts
Investigational New Drugs
|
September 17, 2013
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers
Terry H Landowski, Betty K Samulitis, Robert T Dorr
Anticancer Research
|
August 27, 2011
Interaction of dacarbazine and imexon, in vitro and in vivo, in human A375 melanoma cells
Betty K Samulitis, Robert T Dorr, H-H Sherry Chow
Page
of 19